Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04090775
What this trial is testing

Trial for Men With Metastatic Prostatic Adenocarcinoma

Who this might be right for
Metastatic Prostatic Adenocarcinoma
Rampart Health, L.L.C. 12
Large-scale testing (Phase 3)Looking for participantsNCT01492972
What this trial is testing

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Collaborative Group 192
Not applicableLooking for participantsNCT06141993
What this trial is testing

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Metastatic+1 more
Duke University 120
Testing effectiveness (Phase 2)Study completedNCT00715078
What this trial is testing

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Who this might be right for
Prostate Cancer
Dendreon 122
Early research (Phase 1)Study completedNCT00061035
What this trial is testing

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

Who this might be right for
Prostatic Neoplasms
Cosmo Bioscience 18
Testing effectiveness (Phase 2)Study completedNCT03279250
What this trial is testing

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 86
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084
What this trial is testing

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Who this might be right for
Prostate Adenocarcinoma
NRG Oncology 2,050
Not applicableStudy completedNCT03368547
What this trial is testing

68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v7Stage III Prostate Cancer AJCC v7+1 more
Jonsson Comprehensive Cancer Center 400
Testing effectiveness (Phase 2)Ended earlyNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT02262455
What this trial is testing

Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+1 more
Santa Maria Biotherapeutics 32
Testing effectiveness (Phase 2)Looking for participantsNCT05914116
What this trial is testing

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors
DualityBio Inc. 862
Large-scale testing (Phase 3)Study completedNCT00002855
What this trial is testing

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 306
Not applicableStudy completedNCT02375776
What this trial is testing

Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention

Who this might be right for
Renal Cell CancerProstate CancerEffects of Chemotherapy
Massachusetts General Hospital 84
Large-scale testing (Phase 3)Study completedNCT00002760
What this trial is testing

Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 260
Large-scale testing (Phase 3)Looking for participantsNCT07200830
What this trial is testing

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Who this might be right for
Metastatic Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,524
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Early research (Phase 1)Study completedNCT00911118
What this trial is testing

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00027794
What this trial is testing

Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 40
Not applicableUnknownNCT04192890
What this trial is testing

Efficacy and Safety Assessment of IRE of Localized Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
I.M. Sechenov First Moscow State Medical University 12
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Next Page